eCARTv5 Clinical Deterioration Suite (“eCART”) vs Kahun

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A (eCARTv5) is an FDA-cleared AI that continuously assesses and predicts clinical deterioration in hospitalized patients, guiding care with embedded clinical pathways. Tool B (Kahun) is an AI-powered clinical reasoning tool that assists physicians with differential diagnoses, test recommendations, and treatment suggestions based on a vast medical knowledge base. While both are clinical decision support tools, eCARTv5 focuses on proactive risk prediction for hospitalized patients, whereas Kahun aids in diagnostic and treatment planning across a broader range of patient scenarios.

Choose eCARTv5 Clinical Deterioration Suite (“eCART”) if…

Choose AgileMD's eCARTv5 if your primary need is continuous, real-time monitoring and prediction of clinical deterioration in hospitalized adult patients. This FDA-cleared, AI-powered tool excels at early warning for events like death or ICU transfer, integrating directly with EHRs to guide care teams with embedded clinical pathways and minimize false alarms.

View eCARTv5 Clinical Deterioration Suite (“eCART”) →

Choose Kahun if…

Choose Kahun if your focus is on assisting physicians with clinical reasoning, including generating differential diagnoses, recommending tests, and suggesting treatments. This AI-powered platform leverages a vast and continuously updated medical knowledge base to provide evidence-based support, helping to improve diagnostic accuracy and streamline the decision-making process for a wide range of patient presentations.

View Kahun →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) Kahun
Pricing Contact vendor for tailored quote. Subscription
Deployment Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems. Kahun integrates with EMR systems.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Unknown
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 is praised for its intuitive interface and seamless integration with existing EHR workflows, simplifying order entry and documentation for healthcare providers. Users highlight its user-friendly design and real-time insights as superior to standalone tools. While Kahun aims for a user-friendly interface and offers a mobile app, specific user reviews on its ease of use in clinical workflows are less detailed compared to AgileMD's documented strengths in EHR integration and streamlined processes.

Clinical Value

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 is an FDA-cleared SaMD that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, with strong evidence of accuracy and early warning capabilities. It has been validated in extensive clinical performance data from nearly two million hospitalizations across 21 hospitals. Kahun, while providing AI-powered differential diagnoses and treatment suggestions based on a vast medical knowledge base, has clinical evidence primarily from studies evaluating its data-gathering function and diagnostic performance against medical board exams, rather than direct impact on patient outcomes in real-time hospital settings.

Pricing & Value

Tie

Both AgileMD's eCARTv5 and Kahun offer subscription-based pricing models and encourage prospective customers to contact the vendor for a tailored quote, indicating a lack of public pricing transparency. AgileMD's pricing is noted to start in the range of $10-$100, but this is still a broad estimate. Without more specific pricing details or publicly available ROI studies for both tools, it is difficult to definitively determine which offers superior value.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 is designed for rapid, seamless implementation at scale in days to weeks, not months to years, and is built to tough CIO standards, including SOC-II and HIPAA compliance with robust security architecture. It has been deployed in over 400 hospitals and has been tested on nearly 3 million patient encounters. Kahun integrates with EMR systems and is HIPAA and GDPR compliant, but there is less information available regarding its large-scale deployment capabilities, implementation timelines, or specific enterprise-level security certifications beyond HIPAA and GDPR.

Innovation

Tie

AgileMD's eCARTv5 leverages a gradient-boosted machine learning model trained on a multi-center dataset of over 800,000 patient records, utilizing up to 97 variables for highly accurate deterioration prediction. Kahun's innovation lies in its proprietary knowledge graph, which contains over 30 million medical insights derived from professional literature, aiming to replicate clinical reasoning and provide explainable AI. Both represent significant advancements in their respective areas of clinical AI, making a definitive winner difficult to choose without further comparative analysis of their underlying AI methodologies and their impact on clinical practice.

Support & Docs

Tie

AgileMD offers various training resources including documentation, in-person, live online, videos, and webinars, along with email, phone, chat, FAQ, forum, help desk, knowledge base, tickets, and 24/7 live support. While Kahun emphasizes its user-friendly interface and the availability of original sources for its algorithm's suggestions, detailed information about its comprehensive support and documentation offerings for enterprise clients is not as readily available as for AgileMD. Therefore, based on the provided information, it's a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) Kahun
Name eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d) Kahun
Company AgileMD Kahun
Description FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. AI-powered clinical reasoning tool that assists physicians with differential diagnoses, test recommendations, and treatment suggestions based on a vast medical knowledge base.
Key Features AI-powered clinical deterioration prediction; Continuous patient risk assessment (death or ICU transfer); EHR integration with real-time data (up to 97 variables); Embedded clinical pathways for care guidance; Early warning system (alerts hours before critical illness); Risk stratification (eCART score and risk designation); Minimizes false alarms and clinician workload; Reporting and benchmarking capabilities AI-powered differential diagnosis; Evidence-based treatment recommendations; Relevant test suggestions; Continuously updated medical knowledge base; EMR integration capabilities; User-friendly interface; HIPAA compliant; Clinical reasoning support

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (“eCART”) and Kahun.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

eCARTv5 is designed for direct integration into EHR systems, analyzing up to 97 real-time variables to provide continuous patient risk assessment and guide care through embedded clinical pathways. Kahun also integrates with EMR systems to assist with differential diagnoses, test recommendations, and treatment suggestions, aiming to streamline diagnostic processes.
eCARTv5 has been validated through extensive clinical performance data from nearly two million hospitalizations across 21 hospitals, demonstrating consistent accuracy in predicting clinical deterioration (death or ICU transfer). In retrospective validation, eCART had an AUROC of 0.835, outperforming NEWS and MEWS. Kahun demonstrated the best overall performance among chatbot symptom-checkers in a study evaluating their data-gathering function.
eCARTv5 is primarily designed for critical care, emergency medicine, and hospital medicine, focusing on the early detection and management of clinical deterioration in hospitalized adult patients. Kahun, as a clinical reasoning tool for differential diagnoses and treatment suggestions, is well-suited for family medicine, hospital medicine, and internal medicine.
eCARTv5 integrates directly into the EHR and guides clinical staff to embedded clinical pathways, suggesting a streamlined workflow. Kahun emphasizes a user-friendly interface, which could contribute to a shorter learning curve for physicians utilizing it for clinical reasoning support.
eCARTv5 is embedded into the EHR and utilizes real-time variables, with its security and privacy features tied into the existing EHR infrastructure. Kahun is GDPR compliant in addition to being HIPAA compliant, indicating adherence to broader data protection regulations.
While not explicitly detailed for either tool, EHR systems generally maintain audit trails that record clinicians' interactions for security and privacy purposes, which can be used to analyze clinical workflow. Deep integration with EHRs, as both tools offer, would likely leverage these existing audit capabilities.
eCARTv5 has been validated across 21 hospitals from three health systems, suggesting its adaptability for multi-site deployments and diverse patient demographics. Kahun's EMR integration capabilities imply a design that can accommodate different system configurations, though specific multi-site rollout details are not provided.
AI Tool Finder
AI-powered search. Results may not be comprehensive.